3064.0: Monday, October 22, 2001: 12:30 PM-2:00 PM | ||||
Roundtable Session | ||||
| ||||
In 1996 the National Institute for Occupational Safety and Health unveiled an occupational safety and health research agenda that had been the product of a year-long stakeholder process involving over 500 institutions and individuals from academia, labor, industry and other federal and state government agencies. Twenty-one priority areas emerged that represented serious issues likely to be responsive to concerted research efforts but traditionally not adequately studied; twenty teams (the priority areas for upper extremity and lower back musculoskeletal disorders were merged into one team) have worked to keep widespread stakeholder involvement, identify and implement partnerships, and leverage resources to target the 21 NORA priority areas. These range from the relatively straightforward, such as Teams targeting disease and injury, (eg, fertility and pregnancy abnormalities, hearing loss, traumatic injuries), to those focused on emerging issues in the work environment and workforce (eg, mixed exposures, organization of work, special populations at risk), to the need for new research tools and approaches (eg, health services research, risk assessment methods, social and economic consequences of workplace illness and injury). What are the products so far? What are the successes and the failures? What lessons have been learned? What is happening and what is changing? The roundtable participants will share their experiences as NORA Team leaders. This will be an interactive session with an emphasis on questions and answers; the final third of the session will be reserved for individual audience discussions with Team leaders and representatives. | ||||
See individual abstracts for presenting author's disclosure statement. | ||||
Learning Objectives: N/A | ||||
Rosemary Sokas, MD, MOH | ||||
Special Populations at Risk NORA Team Rosemary Sokas, MD, MOH, Tom Waters, PhD | ||||
Traumatic Injuries NORA Team Nancy Stout, EdD | ||||
Intervention Effectiveness Research NORA Team Ray Sinclair, PhD | ||||
Social and Economic Consequences of Workplace Illness and Injury NORA Team Elyce Biddle, PhD, Scott Deitchman, MD, MPH | ||||
Allergic and Irritant Dermatitis NORA Team Boris Lushniak, MD, MPH, Darryl Alexander, MA | ||||
Cancer Research Methods NORA Team Elizabeth Ward, PhD | ||||
Organization of Work NORA Team Elizabeth Ward, PhD, Jane Lipscomb, RN, PhD | ||||
Asthma and COPD NORA Team Paul Henneberger, MPH, ScD | ||||
Fertility and Pregnancy Abnormalities Theresa Schnorr, PhD | ||||
Risk Assessment Methods NORA Team Mark Toraason, PhD | ||||
National occupational research agenda (NORA) at mid-life Rosemary Sokas, MD, MOH | ||||
Sponsor: | Occupational Health and Safety | |||
Cosponsors: | Injury Control and Emergency Health Services | |||
CE Credits: | CME, Health Education (CHES), Nursing, Pharmacy, Social Work |